Drug Actives from Bench into Market.
Home About Girindus Capabilities Investor Relations Contact us Sitemap
Deutsch
IR
Investor Relations
News
Corporate Calendar
IR Contacts
Financial Reports
Shareholder Meeting
Archive
Factsheet
Stock Quote

Your  direct  line

For information on Girindus, please contact:

Ralf Penner
Investor Relations

Tel.: +49 2204 926900
Fax: +49 2204 926990
rpenner@girindus.com

back to top